aTyr Pharma Inc (LIFE)
1.60
-0.02
(-1.23%)
USD |
NASDAQ |
Apr 24, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Total Return Level: 1.60 for April 24, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 24, 2024 | 1.60 |
April 23, 2024 | 1.62 |
April 22, 2024 | 1.64 |
April 19, 2024 | 1.60 |
April 18, 2024 | 1.62 |
April 17, 2024 | 1.59 |
April 16, 2024 | 1.61 |
April 15, 2024 | 1.70 |
April 12, 2024 | 1.74 |
April 11, 2024 | 1.76 |
April 10, 2024 | 1.77 |
April 09, 2024 | 1.72 |
April 08, 2024 | 1.83 |
April 05, 2024 | 1.86 |
April 04, 2024 | 1.87 |
April 03, 2024 | 1.85 |
April 02, 2024 | 1.84 |
April 01, 2024 | 1.91 |
March 28, 2024 | 1.95 |
March 27, 2024 | 2.00 |
March 26, 2024 | 1.915 |
March 25, 2024 | 1.92 |
March 22, 2024 | 1.95 |
March 21, 2024 | 2.02 |
March 20, 2024 | 2.02 |
Date | Value |
---|---|
March 19, 2024 | 2.00 |
March 18, 2024 | 1.955 |
March 15, 2024 | 1.99 |
March 14, 2024 | 1.62 |
March 13, 2024 | 1.63 |
March 12, 2024 | 1.62 |
March 11, 2024 | 1.60 |
March 08, 2024 | 1.59 |
March 07, 2024 | 1.66 |
March 06, 2024 | 1.70 |
March 05, 2024 | 1.67 |
March 04, 2024 | 1.79 |
March 01, 2024 | 1.91 |
February 29, 2024 | 1.92 |
February 28, 2024 | 1.90 |
February 27, 2024 | 2.00 |
February 26, 2024 | 1.94 |
February 23, 2024 | 1.91 |
February 22, 2024 | 1.89 |
February 21, 2024 | 1.97 |
February 20, 2024 | 1.88 |
February 16, 2024 | 2.02 |
February 15, 2024 | 1.925 |
February 14, 2024 | 1.92 |
February 13, 2024 | 1.91 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.11
Minimum
Nov 14 2023
12.48
Maximum
Sep 23 2021
3.805
Average
3.66
Median
Sep 28 2020
Total Return Level Benchmarks
Vaxart Inc | 1.855 |
Allogene Therapeutics Inc | 3.04 |
AIM ImmunoTech Inc | 0.43 |
Protalix BioTherapeutics Inc | 1.21 |
Armata Pharmaceuticals Inc | 2.50 |